Dendreon Corporation - Generalhttp://investor.dendreon.com/releases.cfm?sh_auth=0.0.0.ad1dcb691ef81696c0c02ea27e385165Dendreon Corporation - Generalen-usShareholder.com RSS FeedDendreon Announces Presentation of PROVENGE® (sipuleucel-T) Data at the 2013 ASCO Annual Meetinghttp://investor.dendreon.com/releasedetail.cfm?ReleaseID=768341Fri, 31 May 2013 12:00:00 GMThttp://investor.dendreon.com/releasedetail.cfm?ReleaseID=768341Dendreon Announces Presentation of PROVENGE® (sipuleucel-T) Data at the 2013 ASCO Annual MeetingDendreon Announces First Quarter 2013 Resultshttp://investor.dendreon.com/releasedetail.cfm?ReleaseID=763491Thu, 09 May 2013 12:30:00 GMThttp://investor.dendreon.com/releasedetail.cfm?ReleaseID=763491Dendreon Announces First Quarter 2013 ResultsPROVENGE® (sipuleucel-T) Data Presented at An Annual Scientific Urology Meetinghttp://investor.dendreon.com/releasedetail.cfm?ReleaseID=762266Mon, 06 May 2013 17:30:00 GMThttp://investor.dendreon.com/releasedetail.cfm?ReleaseID=762266PROVENGE® (sipuleucel-T) Data Presented at An Annual Scientific Urology MeetingDendreon to Host Conference Call on May 9 to Announce First Quarter Financial Resultshttp://investor.dendreon.com/releasedetail.cfm?ReleaseID=759073Wed, 24 Apr 2013 20:05:00 GMThttp://investor.dendreon.com/releasedetail.cfm?ReleaseID=759073Dendreon to Host Conference Call on May 9 to Announce First Quarter Financial ResultsDendreon Announces Securities Class Action Settlementhttp://investor.dendreon.com/releasedetail.cfm?ReleaseID=749097Mon, 18 Mar 2013 12:30:00 GMThttp://investor.dendreon.com/releasedetail.cfm?ReleaseID=749097Dendreon Announces Securities Class Action SettlementDendreon Announces Webcast Presentation at ROTH Conferencehttp://investor.dendreon.com/releasedetail.cfm?ReleaseID=747702Tue, 12 Mar 2013 23:00:00 GMThttp://investor.dendreon.com/releasedetail.cfm?ReleaseID=747702Dendreon Announces Webcast Presentation at ROTH ConferenceDendreon Announces Fourth Quarter and 2012 Year End Resultshttp://investor.dendreon.com/releasedetail.cfm?ReleaseID=742694Mon, 25 Feb 2013 12:30:00 GMThttp://investor.dendreon.com/releasedetail.cfm?ReleaseID=742694Dendreon Announces Fourth Quarter and 2012 Year End ResultsNew PROVENGE® (sipuleucel-T) Data to Be Presented at 2013 American Society of Clinical Oncology (ASCO) Genitourinary Cancers Symposiumhttp://investor.dendreon.com/releasedetail.cfm?ReleaseID=739948Wed, 13 Feb 2013 13:00:00 GMThttp://investor.dendreon.com/releasedetail.cfm?ReleaseID=739948New PROVENGE® (sipuleucel-T) Data to Be Presented at 2013 American Society of Clinical Oncology (ASCO) Genitourinary Cancers SymposiumDendreon to Host Conference Call on February 25 to Announce Fourth Quarter and Full Year 2012 Financial Results and Webcast Presentations at Upcoming Conferenceshttp://investor.dendreon.com/releasedetail.cfm?ReleaseID=736742Wed, 30 Jan 2013 13:30:00 GMThttp://investor.dendreon.com/releasedetail.cfm?ReleaseID=736742Dendreon to Host Conference Call on February 25 to Announce Fourth Quarter and Full Year 2012 Financial Results and Webcast Presentations at Upcoming ConferencesDendreon Announces Preliminary Fourth Quarter 2012 Revenueshttp://investor.dendreon.com/releasedetail.cfm?ReleaseID=731767Mon, 07 Jan 2013 14:00:00 GMThttp://investor.dendreon.com/releasedetail.cfm?ReleaseID=731767Dendreon Announces Preliminary Fourth Quarter 2012 Revenues